India: Goldman Sachs to invest $150m in Biocon Biologics

India: Goldman Sachs to invest $150m in Biocon Biologics

Biocon Chairperson Kiran Mazumdar-Shaw. Photo: Reuters

Pramugdha Mamgain

10 November, 2020

Biocon Biologics Biocon Ltd Goldman Sachs

Printed by Unregistered user on Thu, 01 Jan 2026 19:19:53 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

India Digest: Biocon Biologics, RMZ Corp in talks to raise funding

India: True North to buy 2.4% stake in Biocon Biologics at $3b valuation

Read more from India

India’s KFC, Pizza Hut operators to merge in $934m deal

India: Financial services tops funding in 2025 despite overall slowdown